IO Biotech
IOBT
IOBT
19 hedge funds and large institutions have $76.9M invested in IO Biotech in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$141K | |
| 2 | +$76K | |
| 3 | +$59K | |
| 4 |
Morgan Stanley
New York
|
+$39.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.2K |
Top Sellers
| 1 | -$758K | |
| 2 | -$323K | |
| 3 | -$98K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$86K |
| 5 |
VF
Virtu Financial
New York
|
-$83K |